Search Orphan Drug Designations and Approvals
-
Generic Name: | peritoneal dialysis solution containing combination of D-glucose and L-carnitine |
---|---|
Date Designated: | 02/21/2019 |
Orphan Designation: | Treatment of patients with end stage renal disease who require peritoneal dialysis |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
CoreQuest Sagl Stabile Suglio Via Cantonale 18 Manno TI, Tessin Switzerland The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-